Ever since penicillin was discovered in 1928, antibiotics have saved countless lives. But they are also among the most commonly prescribed drugs. We’ve taken them for granted, and as a result, overused them, to the extent that they’ve gone from being a boon to a bane in many situations.
A team of scientists including researchers at the University and BNL has studied a catalyst that decomposes nerve agents, eliminating their harmful and lethal effects. The research was published in the Journal of Physical Chemistry Letters.
In a high-stakes competition to be held April 23, one of four young scholars will receive the 2019 Discovery Prize, a $200,000 award given to a Stony Brook University faculty member in the STEM disciplines whose research project embraces risk and innovation and embodies the potential of discovery-driven research.
Stony Brook University is launching our first annual “Giving Day,” a 24-hour online fundraising drive. Scheduled for Tuesday, April 30, Giving Day encourages the Stony Brook University community to support the University’s remarkable students, faculty, and staff and to advance Stony Brook Medicine’s mission to provide the highest quality healthcare.
Sharon Nachman is an international leader in the area of pediatric infectious diseases and the treatment of children with AIDS, flu and measles. She has been the principal investigator of more than 30 clinical trials of promising medicines for patients treated at Stony Brook University Hospital. These include international trials in areas such as new vaccines, Lyme disease, and AIDS. She also directs the Maternal Child HIV/AIDS Program.